Recherche en direct
TopFind récupère les correspondances les plus récentes pour votre recherche.
Nous avons examiné 27 résultats en direct pour xeljanz xr et retenu les 3 options qui semblent les plus utiles à comparer en premier.
Les thèmes les plus forts dans cette sélection sont Prescription Drugs et Pharmaceutical.
Source: Pfizer (Thailand) Ltd.
Description
XELJANZ XR is the extended-release formulation of tofacitinib, delivered in 11 mg tablets for once-daily dosing. It is indicated for the treatment of inflammatory conditions like rheumatoid arthritis and psoriatic arthritis where consistent medicine levels are required.
Idéal pour
Once Daily dosing, Long Term maintenance et Chronic inflammation management
Évaluation
Source: Watsons Philippines
Description
The 11mg extended-release (XR) version of Xeljanz (tofacitinib) offered by Watsons Philippines. This formulation provides a steady release of medication and is intended for patients requiring a higher once-daily dosage as prescribed by a medical professional.
Idéal pour
Once Daily dosage users, Extended Release medication, Chronic inflammatory conditions et Online pharmacy users
Évaluation
Source: Pfizer
Description
Xeljanz is a prescription Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis (RA), psoriatic arthritis, and ulcerative colitis. As a brand-name pharmaceutical, it is available in 5mg immediate-release and 11mg extended-release (XR) tablet formulations designed to reduce inflammation and manage symptoms of autoimmune diseases.
Idéal pour
Rheumatoid arthritis patients, Prescribed JAK inhibitors, Autoimmune disease management et Ulcerative colitis treatment
Évaluation
| Comparer | XELJANZ XR | Xeljanz 11mg XR Tablet | Xeljanz (tofacitinib) |
|---|---|---|---|
| Source | Pfizer (Thailand) Ltd. | Watsons Philippines | Pfizer |
| Description | XELJANZ XR is the extended-release formulation of tofacitinib, delivered in 11 mg tablets for once-daily dosing. It is indicated for the treatment of inflammatory conditions like rheumatoid arthritis and psoriatic arthritis where consistent medicine levels are required. | The 11mg extended-release (XR) version of Xeljanz (tofacitinib) offered by Watsons Philippines. This formulation provides a steady release of medication and is intended for patients requiring a higher once-daily dosage as prescribed by a medical professional. | Xeljanz is a prescription Janus kinase (JAK) inhibitor used to treat adults with moderately to severely active rheumatoid arthritis (RA), psoriatic arthritis, and ulcerative colitis. As a brand-name pharmaceutical, it is available in 5mg immediate-release and 11mg extended-release (XR) tablet formulations designed to reduce inflammation and manage symptoms of autoimmune diseases. |
| Idéal pour | Once Daily dosing, Long Term maintenance et Chronic inflammation management | Once Daily dosage users, Extended Release medication, Chronic inflammatory conditions et Online pharmacy users | Rheumatoid arthritis patients, Prescribed JAK inhibitors, Autoimmune disease management et Ulcerative colitis treatment |
| Action | |||
| Évaluation |
Si vous voulez commencer par l'option la plus équilibrée, je vous recommande :
"XELJANZ XR de Pfizer (Thailand) Ltd.."
Je l'ai choisi parce que Offers the convenience of once-daily dosing through its extended-release formulation, supported by Pfizer's official clinical standards.